T
24 ner M r daily plan VA e 8 fo # urn to pag
In this issue: 02 C arotid disease How do CEA, TF-CAS and TCAR compare?
11 Photo gallery VAM 2024 through the lens
04 Aortic disease One-year AAA device data emerge
14 WFVS Global PAD burden explored
09 V ascular nursing 15 Keynote speaker SVN conference comes Karith Foster delivers to a close DEI pearls of wisdom
THURSDAY 20 JUNE 2024 | CONFERENCE EDITION 2
THE OFFICIAL NEWSPAPER OF THE
www.vascularspecialistonline.com
OPENING CEREMONY
SPOT LIGHT
Attendees welcomed to ‘more inclusive, more innovative, and more educational’ VAM By Jocelyn Hudson
“I
urge each one of you to seize this unique opportunity to not only enhance your patient care but also elevate your careers,” SVS President Joseph Mills, MD, advised VAM 2024 attendees during yesterday’s Opening Ceremony. Mills welcomed delegates to the SVS’ home city of Chicago, stressing that VAM “is not just a series of lectures and presentations, but a platform for inspiration, growth and progress.” SVS Program Committee Chair Andres Schanzer, MD, also took to the podium, underlining some highlights of this year’s agenda, including Karith Foster’s keynote on “Finishing the journey to inclusivity through belonging, intention and respect” (see p. 15). Both Schanzer and Postgraduate Committee Chair William Robinson, MD, are due to step down from their roles after VAM 2024. Schanzer personally thanked Robinson for his contribution to the annual meeting, remarking: “VAM today does not look or feel like the VAM in past years—it’s more inclusive, it’s more innovative, and it’s more educational—and much of that positive change has been a direct result of Dr Robinson’s vision for continued growth and evolution.”
OPEN/ENDO
ENDOVASCULAR CFA TREATMENT ASSOCIATED WITH INCREASED RATE OF LONG-TERM CFA-SPECIFIC REINTERVENTION, STUDY FINDS By Jocelyn Hudson
A RECENT STUDY SUGGESTS THAT endovascular treatment of the common femoral artery (CFA) is associated with an increased rate of long-term CFA-specific reintervention, regardless of indication. Nicholas Wells, MA, a medical student at Yale School of Medicine in New Haven, Connecticut, presented this and other key findings from a tertiary care center analysis of open and endovascular treatment of the CFA during yesterday’s William J. von Liebig Forum.
“The CFA is a common site of disease in patients with peripheral arterial disease,” Wells began. He noted that endarterectomy is seen as the gold standard of treatment, with primary patency rates “often surpassing 95% at five years” and evidence of “excellent long-term durability as far out as eight years.” The objective of the study, Wells shared,
See page 2
DAY TWO HIGHLIGHTS
Jumping into day two of VAM 2024, attendees can expect another day of varied science, education and other meeting festivities: award ceremonies, special sessions, the opening of the Exhibit Hall and more. Among them are the General Surgery Resident/ Medical Student Session: Mock Interviews, which is an opportunity for trainees on the traditional track and students to get a feel for the interviews that will soon be in their headlights. The mock interviews will run from 6:30–8 a.m. At 9:30 a.m., the John Homan’s Lecture (see story on p. 13) will focus on what can be learned from international variations in vascular care. Immediately following will be the Awards Ceremony, where the 2024 Lifetime Achievement Award winners along with many others will be honored. The afternoon will feature the fan favorite “How I Do It” video session, along with two membership sections, including the SVS Community Practice Section session focused on the optimization of clinical practice, and the SVS Section on Outpatient and Office Vascular Care session, which will present findings from grant and award recipients. Other events will cover topics like a multidisciplinary approach to limb salvage, dialysis creation and more. Join the Opening Reception in the Exhibit Hall at 5 p.m. happening in conjunction with the International Poster Competition and the Interactive Poster Session.—Kristin Spencer